Feasibility Studies to Inform the Design of Future Clinical Trials
National Institutes of Health
Classification and identifiers
- Solicitation number
- PAR-28-011
- Assistance listing (CFDA)
- 93.213
Amount
Amount not published by the funder
Who can apply
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
About this opportunity
The National Institutes of Health intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications that propose feasibility studies that could inform the design and conduct of subsequent definitive clinical trials (e.g., efficacy, effectiveness, pragmatic, dissemination and implementation, phase/stage II or later trials). Applications to this NOFO should demonstrate that the proposed feasibility research is scientifically necessary to design or plan the subsequent definitive clinical trial. Studies may utilize mixed methods and feasibility clinical trials to assess feasibility of recruitment, randomization, retention, intervention delivery, data collection, adherence, acceptability, and/or develop or adapt intervention components or protocols. The proposed feasibility rese...
Related opportunities
- Building Sustainable Software Tools for Open Science (R03 Clinical Trial Not Allowed)National Institutes of Health
- NIH Pragmatic Trials Conducted in Health Care SystemsNational Institutes of Health
- Clinical Trials and Ancillary Studies Conducted within NIH-Funded Clinical Trial Research Networks (UG3/UH3 - Clinical Trial Required)National Institutes of Health
- NextTech: Translational Development of Next-Generation Diagnostic and Therapeutic Devices (R18 Clinical Trial Not Allowed)National Institutes of Health
- Pilot and Feasibility Studies in Preparation for Substance Use and HIV Prevention Intervention and Services Research TrialsNational Institutes of Health
- HIV/AIDS Clinical Trials Network Clinical Trials UnitsNational Institutes of Health